HUP0203269A2 - Method for the detection of mammalian carcinomas - Google Patents
Method for the detection of mammalian carcinomasInfo
- Publication number
- HUP0203269A2 HUP0203269A2 HU0203269A HUP0203269A HUP0203269A2 HU P0203269 A2 HUP0203269 A2 HU P0203269A2 HU 0203269 A HU0203269 A HU 0203269A HU P0203269 A HUP0203269 A HU P0203269A HU P0203269 A2 HUP0203269 A2 HU P0203269A2
- Authority
- HU
- Hungary
- Prior art keywords
- spatial distribution
- sample
- detection
- component
- specific component
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 201000009030 Carcinoma Diseases 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000013074 reference sample Substances 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 230000009466 transformation Effects 0.000 abstract 2
- 208000035269 cancer or benign tumor Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000003855 cell nucleus Anatomy 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 210000004940 nucleus Anatomy 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99203582 | 1999-11-01 | ||
| PCT/EP2000/011050 WO2001033229A1 (en) | 1999-11-01 | 2000-11-01 | Method for the detection of mammalian carcinomas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0203269A2 true HUP0203269A2 (en) | 2003-02-28 |
Family
ID=8240801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203269A HUP0203269A2 (en) | 1999-11-01 | 2000-11-01 | Method for the detection of mammalian carcinomas |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1226439A1 (ja) |
| JP (1) | JP2003513282A (ja) |
| AU (1) | AU2156501A (ja) |
| CA (1) | CA2389364A1 (ja) |
| HU (1) | HUP0203269A2 (ja) |
| NZ (1) | NZ519065A (ja) |
| WO (1) | WO2001033229A1 (ja) |
| ZA (1) | ZA200203401B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5339676B2 (ja) * | 2003-02-21 | 2013-11-13 | メドベット サイエンス ピーティーワイ． リミテッド | 細胞を検出する方法、およびこれに有用な薬剤 |
| US20090029408A1 (en) * | 2007-07-25 | 2009-01-29 | Wyeth | Methods for Characterizing Cell Proximity |
| EP2467499A1 (en) * | 2009-08-21 | 2012-06-27 | Oncotherapy Science, Inc. | Cstf2 for target genes of lung cancer therapy and diagnosis |
| US11551360B2 (en) | 2020-04-28 | 2023-01-10 | QATAR UNIVERSITY, Office of Academic Research | Device and method for cancer detection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264343A (en) * | 1990-08-31 | 1993-11-23 | Eleanor Roosevelt Institute | Method for distinguishing normal and cancer cells |
| US5599919A (en) * | 1994-12-09 | 1997-02-04 | Fox Chase Cancer Center | Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use |
| US5891857A (en) * | 1996-02-20 | 1999-04-06 | Vanderbilt University | Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
-
2000
- 2000-11-01 EP EP00984990A patent/EP1226439A1/en not_active Withdrawn
- 2000-11-01 CA CA002389364A patent/CA2389364A1/en not_active Abandoned
- 2000-11-01 JP JP2001535063A patent/JP2003513282A/ja active Pending
- 2000-11-01 WO PCT/EP2000/011050 patent/WO2001033229A1/en not_active Application Discontinuation
- 2000-11-01 HU HU0203269A patent/HUP0203269A2/hu unknown
- 2000-11-01 NZ NZ519065A patent/NZ519065A/en unknown
- 2000-11-01 AU AU21565/01A patent/AU2156501A/en not_active Abandoned
-
2002
- 2002-04-29 ZA ZA200203401A patent/ZA200203401B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ519065A (en) | 2004-03-26 |
| ZA200203401B (en) | 2003-04-29 |
| AU2156501A (en) | 2001-05-14 |
| EP1226439A1 (en) | 2002-07-31 |
| CA2389364A1 (en) | 2001-05-10 |
| JP2003513282A (ja) | 2003-04-08 |
| WO2001033229A1 (en) | 2001-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stark et al. | Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms | |
| AU2849300A (en) | Methods and assay kits for detecting mononuclear cell phenotype | |
| Su et al. | Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients | |
| DE69938623D1 (de) | Microarrays und ihre verwendungen | |
| ATE357663T1 (de) | Teilchenförmiges markierungsmittel verwendendes analytassay | |
| AU9198298A (en) | Polymorphism detection utilizing clustering analysis | |
| EP1415152A4 (en) | METHOD, DEVICES AND COMPUTER PROGRAMS FOR VERIFYING THE INTEGRITY OF A PROBE | |
| HUP0303888A2 (hu) | FKBP-nukleinsavak és -polipeptidek prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise | |
| GB2430740A (en) | System and method for tracking and quatitating chemical entites | |
| WO2002000933A3 (en) | Screening assays for identifying modulators of the inflammatory or immune responses | |
| Ciccimaro et al. | Analysis of phosphorylation sites on focal adhesion kinase using nanospray liquid chromatography/multiple reaction monitoring mass spectrometry | |
| Brentnall et al. | Proteins that underlie neoplastic progression of ulcerative colitis | |
| Nong et al. | Comparison of next-generation sequencing and immunohistochemistry analysis for targeted therapy-related genomic status in lung cancer patients | |
| Das et al. | Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma | |
| WO2007056332A3 (en) | Molecular diagnosis of autoimmune diseases | |
| WO2001031056A3 (fr) | Methode de detection par pcr | |
| HUP0203269A2 (en) | Method for the detection of mammalian carcinomas | |
| CA2586654A1 (en) | Use of asc as a marker for colorectal cancer | |
| ATE449868T1 (de) | Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen | |
| AU2003213657A8 (en) | Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof | |
| DK0514490T3 (da) | Allelisk forbindelse af human dopamin (D2) receptorgenet i kompulsionsforstyrrelser, såsom alkoholisme | |
| Chevreux et al. | Quantification of proteins by data independent acquisition: performance assessment of the Hi3 methodology | |
| HUP0303890A2 (hu) | Differenciációs nukleinsavak és polipeptidek inhibitorának prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise | |
| Goldeck et al. | Multi‐parametric phospho‐flow cytometry: A crucial tool for T lymphocyte signaling studies | |
| WO2004024949A3 (en) | Method of rapid detection of mutations and nucleotide polymorphisms using chemometrics |